Geode Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.67M Sell
485,797
-8,408
-2% -$63.6K ﹤0.01% 2888
2025
Q1
$2.73M Buy
494,205
+16,974
+4% +$93.7K ﹤0.01% 2931
2024
Q4
$2.74M Sell
477,231
-120
-0% -$690 ﹤0.01% 3020
2024
Q3
$4.95M Buy
477,351
+14,575
+3% +$151K ﹤0.01% 2762
2024
Q2
$6M Buy
462,776
+20,704
+5% +$269K ﹤0.01% 2624
2024
Q1
$7.72M Buy
442,072
+12,835
+3% +$224K ﹤0.01% 2479
2023
Q4
$4.04M Buy
429,237
+19,537
+5% +$184K ﹤0.01% 2815
2023
Q3
$4.58M Buy
409,700
+5,897
+1% +$65.9K ﹤0.01% 2685
2023
Q2
$8.64M Buy
403,803
+8,727
+2% +$187K ﹤0.01% 2374
2023
Q1
$16M Buy
395,076
+16,135
+4% +$653K ﹤0.01% 1945
2022
Q4
$17.6M Buy
378,941
+15,960
+4% +$742K ﹤0.01% 1853
2022
Q3
$18.8M Buy
362,981
+16,709
+5% +$867K ﹤0.01% 1773
2022
Q2
$16.4M Sell
346,272
-6,444
-2% -$305K ﹤0.01% 1900
2022
Q1
$25.1M Buy
352,716
+16,708
+5% +$1.19M ﹤0.01% 1736
2021
Q4
$25.1M Buy
336,008
+2,215
+0.7% +$166K ﹤0.01% 1801
2021
Q3
$19M Buy
333,793
+3,384
+1% +$192K ﹤0.01% 1994
2021
Q2
$14.5M Buy
330,409
+17,865
+6% +$786K ﹤0.01% 2199
2021
Q1
$15.4M Buy
312,544
+26,964
+9% +$1.33M ﹤0.01% 2044
2020
Q4
$12M Buy
285,580
+10,594
+4% +$446K ﹤0.01% 2041
2020
Q3
$12.6M Buy
274,986
+8,269
+3% +$379K ﹤0.01% 1820
2020
Q2
$13.4M Buy
266,717
+7,942
+3% +$399K ﹤0.01% 1758
2020
Q1
$13.3M Buy
258,775
+27,220
+12% +$1.4M ﹤0.01% 1557
2019
Q4
$14.3M Sell
231,555
-557
-0.2% -$34.4K ﹤0.01% 1764
2019
Q3
$13.9M Buy
232,112
+12,811
+6% +$770K ﹤0.01% 1703
2019
Q2
$18.5M Buy
219,301
+6,858
+3% +$579K ﹤0.01% 1539
2019
Q1
$20.3M Buy
212,443
+13,741
+7% +$1.31M 0.01% 1409
2018
Q4
$14.1M Buy
198,702
+16,732
+9% +$1.19M ﹤0.01% 1533
2018
Q3
$15.6M Buy
181,970
+11,572
+7% +$989K ﹤0.01% 1591
2018
Q2
$19.7M Buy
170,398
+18,078
+12% +$2.1M 0.01% 1364
2018
Q1
$12.3M Buy
152,320
+12,892
+9% +$1.04M ﹤0.01% 1614
2017
Q4
$8.18M Buy
139,428
+1,798
+1% +$105K ﹤0.01% 1887
2017
Q3
$6.44M Buy
137,630
+1,210
+0.9% +$56.6K ﹤0.01% 2043
2017
Q2
$4.91M Buy
136,420
+15,851
+13% +$570K ﹤0.01% 2155
2017
Q1
$3.71M Sell
120,569
-12,015
-9% -$370K ﹤0.01% 2283
2016
Q4
$4.44M Buy
132,584
+6,436
+5% +$216K ﹤0.01% 2138
2016
Q3
$3.36M Buy
126,148
+9,335
+8% +$248K ﹤0.01% 2220
2016
Q2
$2.58M Sell
116,813
-13,505
-10% -$298K ﹤0.01% 2323
2016
Q1
$3.83K Buy
130,318
+22,248
+21% +$653 ﹤0.01% 2043
2015
Q4
$3.57M Buy
108,070
+12,457
+13% +$411K ﹤0.01% 2111
2015
Q3
$3.46M Buy
95,613
+1,960
+2% +$70.8K ﹤0.01% 2084
2015
Q2
$4.21M Buy
93,653
+8,322
+10% +$374K ﹤0.01% 2004
2015
Q1
$2.61M Buy
85,331
+9,408
+12% +$288K ﹤0.01% 2274
2014
Q4
$3.86M Buy
75,923
+20,204
+36% +$1.03M ﹤0.01% 1991
2014
Q3
$2.2M Buy
55,719
+13,320
+31% +$527K ﹤0.01% 2306
2014
Q2
$1.83M Buy
42,399
+12,456
+42% +$536K ﹤0.01% 2426
2014
Q1
$1.2M Buy
29,943
+8,596
+40% +$344K ﹤0.01% 2667
2013
Q4
$582K Sell
21,347
-163
-0.8% -$4.44K ﹤0.01% 3018
2013
Q3
$493K Buy
21,510
+689
+3% +$15.8K ﹤0.01% 2956
2013
Q2
$369K Buy
+20,821
New +$369K ﹤0.01% 3006